HISTORY
-
1983
Commences Operations
Ambitrans Medical Transport, Inc. commenced operations in 1983 with one vehicle providing wheelchair and non-medical stretcher service in Charlotte County, Florida.
-
1988
Purchased by Grant Medical Transportation
In 1988, Ambitrans was purchased by Grant Medical Transportation, Inc. and its new owners, Michael and Lorraine Grant. As a former ambulance inspector and emergency medical technician from Massachusetts, Mike was no stranger to the medical transportation industry.
-
1992 - 1996
Grows Non-Medical Fleet and Expands Services
Over the next four years Ambitrans continued to grow its non-medical fleet with the addition of ambulances to provide Basic Life Support and Advanced Life Support. The expanded services enabled Ambitrans to meet the demand of inter-facility transfers that required a higher level of delivery other than non-medical transportation.
-
Separates Into Divisions
Ambitrans separated its divisions: Ambitrans Ambulance became the ambulance division and Grant Medical Transportation, Inc. (d/b/a Ambitrans) was responsible for providing non-medical transportation through the delivery of wheelchair and non-medical stretcher transports.
-
Provides Diversified Offerings
During this time Ambitrans diversified its offerings and entered the public transportation market by contracting with Charlotte County to operate the county’s “on-demand” transit system. In 2003, through the acquisition of Gene Freedom’s Transport, the non-medical division entered the Sarasota market to provide Baker Act transportation. These services were later expanded to include Marchman Act transports.
-
Expands Corporate Offerings in Southwest Florida
As the years passed, Ambitrans has continued to expand its geographical region and corporate offerings. Today, the ambulance division services Southwest Florida (Collier, Lee, Charlotte, Sarasota and Manatee counties.) Our expanding fleet of vehicles is capable of rendering Basic Life Support, Advanced Life Support and Critical Care Ambulance services.